CD21 positive B cell: a novel target for treatment of multiple sclerosis.
Farjam, Mojtaba
CD21 positive B cell: a novel target for treatment of multiple sclerosis. [electronic resource] - Medical hypotheses May 2013 - 556-7 p. digital
Publication Type: Journal Article
1532-2777
10.1016/j.mehy.2013.01.016 doi
Anti-Inflammatory Agents--therapeutic use
B-Lymphocytes--drug effects
Epstein-Barr Virus Infections--drug therapy
Humans
Models, Immunological
Multiple Sclerosis--drug therapy
Receptors, Complement 3d--antagonists & inhibitors
CD21 positive B cell: a novel target for treatment of multiple sclerosis. [electronic resource] - Medical hypotheses May 2013 - 556-7 p. digital
Publication Type: Journal Article
1532-2777
10.1016/j.mehy.2013.01.016 doi
Anti-Inflammatory Agents--therapeutic use
B-Lymphocytes--drug effects
Epstein-Barr Virus Infections--drug therapy
Humans
Models, Immunological
Multiple Sclerosis--drug therapy
Receptors, Complement 3d--antagonists & inhibitors